Want to join the conversation?
$SNA 2Q15 Q&A: Vruwink from Baird about diagnostic longer term growth profile for the business. Nick explained that we still have a lot of run way in terms of what I would call the downtown diagnostics. It’s a very important product line for us. In fact, we feel pretty positive about the possibilities and the opportunity for that opportunity.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?